CN112691130A - Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation - Google Patents
Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation Download PDFInfo
- Publication number
- CN112691130A CN112691130A CN202110172782.7A CN202110172782A CN112691130A CN 112691130 A CN112691130 A CN 112691130A CN 202110172782 A CN202110172782 A CN 202110172782A CN 112691130 A CN112691130 A CN 112691130A
- Authority
- CN
- China
- Prior art keywords
- extract
- pharmaceutical formulation
- gastrointestinal diseases
- medicine
- treating gastrointestinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 208000018522 Gastrointestinal disease Diseases 0.000 title claims abstract description 19
- 239000000284 extract Substances 0.000 title claims abstract description 18
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 14
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 235000017823 Medicago polymorpha Nutrition 0.000 claims description 7
- 244000173297 Medicago polymorpha Species 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 241000005787 Cistanche Species 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 244000085625 Equisetum Species 0.000 claims 1
- 240000004274 Sarcandra glabra Species 0.000 claims 1
- 235000010842 Sarcandra glabra Nutrition 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 208000007882 Gastritis Diseases 0.000 abstract description 13
- 241000590002 Helicobacter pylori Species 0.000 abstract description 12
- 229940037467 helicobacter pylori Drugs 0.000 abstract description 12
- 206010010774 Constipation Diseases 0.000 abstract description 8
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 7
- 201000005917 gastric ulcer Diseases 0.000 abstract description 7
- 208000023652 chronic gastritis Diseases 0.000 abstract description 6
- 206010009900 Colitis ulcerative Diseases 0.000 abstract description 5
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract description 5
- 241000233779 Cyclocarya paliurus Species 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000003467 diminishing effect Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 208000035143 Bacterial infection Diseases 0.000 abstract description 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 2
- 208000018556 stomach disease Diseases 0.000 abstract description 2
- 238000005303 weighing Methods 0.000 description 15
- 241000238421 Arthropoda Species 0.000 description 14
- 238000001914 filtration Methods 0.000 description 11
- 241000475042 Stolonifera Species 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 4
- 210000001156 gastric mucosa Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 201000009906 Meningitis Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 241001148683 Zostera marina Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241001645754 Ardisia pusilla Species 0.000 description 1
- 241000726094 Aristolochia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000722808 Arthrobotrys Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000001762 Gastric Dilatation Diseases 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000219991 Lythraceae Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001672662 Odontoglossum Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000034817 Waterborne disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BBFQZRXNYIEMAW-UHFFFAOYSA-N aristolochic acid I Chemical compound C1=C([N+]([O-])=O)C2=C(C(O)=O)C=C3OCOC3=C2C2=C1C(OC)=CC=C2 BBFQZRXNYIEMAW-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 229930193974 gastrodin Natural products 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000023984 stomach polyp Diseases 0.000 description 1
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 1
- 229960004291 sucralfate Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000009025 weibizhi Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses application of cyclocarya paliurus and an extract thereof in preparing a medicine for treating gastrointestinal diseases and a medicine formula, wherein the medicine formula contains the cyclocarya paliurus or the extract thereof, and the medicine formula also contains Yunnan white-drug-one-mouth handleless cup; the traditional Chinese medicine composition has a special effect on diminishing inflammation and sterilizing helicobacter pylori, effectively inhibits bacterial infection, prevents helicobacter pylori from spreading in a human body, can quickly treat gastric diseases such as gastric ulcer, antral gastritis, chronic gastritis and gastrectasia, and has a special curative effect on constipation caused by ulcerative colitis.
Description
Technical Field
The invention relates to the technical field of medicines, in particular to application of arthrobotrys rotundifolia and an extract thereof in preparing a medicine for treating helicobacter pylori and gastrointestinal diseases and a medicine formula thereof.
Background
The stomach is primarily the place where the body will help digest and grind food, including storing food. Gastrointestinal disorders refer to disorders of the stomach. In China, the proportion of patients with gastrointestinal diseases is very high, the main symptoms of the gastrointestinal diseases comprise abdominal stomach and wrist discomfort, pain, postprandial distention, eructation, acid regurgitation, nausea, vomiting and the like, and the clinically common gastrointestinal diseases comprise acute gastritis, chronic gastritis, gastric ulcer, duodenal ulcer, gastroduodenal complex ulcer, gastric polyp, gastric calculus, benign and malignant tumors of stomach, prolapse of gastric mucosa, acute gastric dilatation, pyloric obstruction and the like. At present, more western medicines and medicines are used for treating gastrointestinal diseases, such as acid-resistant medicines, and are used for neutralizing and inhibiting gastric acid secretion, so that the gastric acidity is reduced, the activity of pepsin is inhibited, and the attack factor of the stomach is reduced. Such drugs as Weishuping, Weibizhi, Weidele, etc.; secondly, the gastric mucosa is protected to combine with pepsin to inhibit the protease from decomposing protein, and can be combined with the protein of the gastric mucosa to form a protective covering ulcer surface, which is beneficial to mucosa regeneration and promotes ulcer healing. Such drugs as gastrodin, sucralfate, colloidal bismuth, etc.; antibiotics for killing helicobacter pylori, promoting HP to turn negative and benefiting improvement of chronic gastritis, such as metronidazole, colloidal bismuth, tetracycline and the like. The Chinese patent medicine has the functions of diminishing inflammation, relieving pain, promoting qi circulation and invigorating stomach, and is prepared by the following raw materials: promoting digestion, relieving flatulence, promoting qi circulation, and relieving pain, such as radix aucklandiae pill, pill for relieving chest stuffiness and diaphragm, and WEIFU granule; warming middle-jiao and regulating stomach, promoting qi circulation and resolving stagnation, such as XIANGSHAYANGWEI pill, BUPIYICHANG pill, etc.; inhibiting acid, relieving pain, and promoting gastric mucosa regeneration such as WEIKANG Capsule; although the curative effect of the traditional Chinese medicine and western medicine at present has the effects of controlling the illness state and healing, the recurrence rate is high, the radical treatment effect is not obvious, but the western medicine generally has the defects of large side effect (rash, hypotension, nausea, vomit, dizziness, hypoglycemia and the like), high price and many contraindications; most of the medicines have complex compositions, and part of the raw materials are difficult to purchase in the market, so the medicine has low cure rate, easy relapse after recovery, unobvious curative effect and long treatment course. The herba Aristolochiae rotundifolii is a plant of the genus Aristolochia of the family Lythraceae, and the whole herb can be used as medicine, and has the following medicinal value: sweet in taste; diluting; is cool in nature. Meridian tropism: the liver and kidney meridians. Can dissipate blood stasis and stop bleeding; eliminating dampness and removing toxic substance. Traumatic injury is mainly caused; bleeding due to internal and external injury; fracture of the bone; rheumatic arthralgia; snake bite; carbuncle sore and pyogenic infections; scabies; dysentery; gonorrhea; water tympany; acute hepatitis; carbuncle, swelling and sore; swelling and aching of gum; hemorrhoids; acute mastitis; acute meningitis; acute pharyngolaryngitis; menoxenia; dysmenorrhea; scald and burn; the herbal and wood formula records that all the herbs are toxic to fire and can promote diuresis, clear heat, relieve carbuncle and swelling and remove heat-toxin. It is indicated for stranguria, dysentery and hemorrhoid due to fire and damp invasion of decoction. The book Guiyang folk herb is loaded with the medicine for treating cough and water-borne diseases. "(the four Chuan Zhi Shi): clearing away heat and toxic material, relaxing bowels and eliminating swelling. It is indicated for swelling and pain of gum, abscess and toxicity. ".
Disclosure of Invention
The invention aims to provide the application of the ardisia pusilla and the extractive thereof in preparing the medicine for treating the gastrointestinal diseases (helicobacter pylori) and the medicine formula thereof, and the formula can be orally taken without obvious toxic and side effects.
In order to achieve the purpose, the technical scheme adopted by the invention for solving the technical problem is as follows:
use of Arthropoda scholaris and its extract in preparing medicine for treating gastrointestinal diseases, such as gastrointestinal diseases caused by helicobacter pylori, gastric ulcer, antral gastritis, chronic gastritis, gastrectasia, and constipation caused by ulcerative colitis is disclosed.
Preferably, the extract comprises liquid or solid obtained by ethanol extraction or water extraction of the burclover and a mixture thereof, wherein the ethanol extraction comprises ethanol extraction, the burclover is crushed and then added with ethanol for low-temperature crushing at 0-4 ℃, the ethanol concentration is 50-75 percent by mass, the liquid is filtered after extraction for ethanol removal, so that the extract is obtained, and the extract can also be dried to obtain the solid; secondly, water extraction comprises the steps of placing the burclover into water, homogenizing and crushing the burclover at high speed at 0-5 ℃ by a homogenizer, boiling extracted liquid, and performing rotary volatilization on the liquid to obtain liquid or solid; the mixture comprises the mixture of extracts obtained by alcohol extraction and water extraction.
A pharmaceutical formulation for treating helicobacter pylori, gastrointestinal diseases, said pharmaceutical formulation comprising Arthropoda rotundifolia or an extract thereof.
Preferably, the medicine formula also comprises a handless cup, has the functions of dispelling wind and dissipating heat, inhibiting bacteria and diminishing inflammation, and preventing corrosion and relieving itching, and is used for preventing influenza and epidemic cerebrospinal meningitis and treating upper respiratory tract infection, sphagitis, bronchitis and pneumonia; it can be used for treating burn, scald, and cellulitis. The addition of fructus Eucalypti Robustae can improve the therapeutic effect of gastric ulcer and helicobacter pylori, and shorten the treatment course.
Preferably, the weight percentage of the zostera marina or the extract thereof in the medicinal formula is m, the content of 0% < m < 100%, wherein the weight percentage of the zostera marina is 100%, the content is 5-100g, and the treatment effect on constipation, helicobacter pylori, antral gastritis and chronic gastritis caused by ulcerative colitis can be remarkably improved without relapse.
Preferably, the mass fraction ratio of the leaf of round leaf burclover or the extract thereof to the herba cistanches in the medicinal formula is 1: 0.01-0.5.
Preferably, the pharmaceutical formulation can be made into raw slices, tablets, pills, capsules, suspensions, aqueous solutions, powders or emulsions.
The invention has the following beneficial effects:
the invention can quickly treat stomach diseases such as helicobacter pylori sterilization, gastric ulcer, antral gastritis, gastrectasia, chronic gastritis and the like, has special effect and special curative effect on constipation caused by ulcerative colitis, has special effect on the helicobacter pylori anti-inflammation sterilization, effectively inhibits bacterial infection, and prevents helicobacter pylori from spreading in human body from the source, and has low cost, quick effect, cure rate of more than 90 percent and small recurrence possibility.
Detailed Description
The present invention is further described in detail with reference to specific examples, so that those skilled in the art can implement the invention with reference to the description.
The materials used in the examples were all purchased at a pharmacy.
Example 1
Weighing dried Arthropoda stolonifera 5g, adding 400ml water, decocting to 100ml, filtering, and collecting liquid.
Example 2
Weighing 20g of dried Arthropoda stolonifera, adding 400ml of water, boiling to 100ml, and filtering to obtain liquid.
Example 3
Weighing 35g of dried Arthropoda stolonifera, adding 400ml of water, boiling to 100ml, and filtering to obtain liquid.
Example 4
Weighing 50g of dried Arthropoda stolonifera, adding 400ml of water, boiling to 100ml, and filtering to obtain liquid.
Example 5
Weighing 65g of dried Arthropoda stolonifera, adding 600ml of water, cooking to 100ml, and filtering to obtain liquid.
Example 6
Weighing 80g of dried Arthropoda stolonifera, adding 600ml of water, cooking to 100ml, and filtering to obtain liquid.
Example 7
Weighing dried Arthropoda stolonifera 95g, adding 600ml water, decocting to 100ml, filtering, and collecting liquid.
Example 8
Weighing 100g of dried Arthropoda stolonifera, adding 600ml of water, cooking to 100ml, and filtering to obtain liquid.
Example 9
The leaf of Odontoglossum was not dried as in example 2.
Example 10
Weighing dried leaf of Arthropoda japonica 20g, adding fructus Eucalypti Robustae 0.2g, adding 400ml water, decocting to 100ml, filtering, and collecting liquid.
Example 11
Weighing dried Arthropoda stolonifera 20g and handless cup 10g, adding 400ml of water, decocting to 100ml, filtering and collecting liquid.
Example 12
Weighing dried Arthropoda stolonifera 20g and handless cup 5g, adding 400ml of water, decocting to 100ml, filtering, and collecting liquid.
Example 13
Weighing 20g of dried Arthropoda rotundifolia, crushing into powder, adding an auxiliary material medicinal binder, and making into tablets.
Example 14
Weighing 20g of dried cyclocarya paliurus and 5g of herba Lobeliae chinensis, weighing 20g of dried cyclocarya paliurus, pulverizing into powder, adding adjuvant medicinal binder, and making into tablet.
Toxicity test was performed: the mice of examples 1-14 were tested, the mice were adult mice weighing 40-50g, the mice were divided into 43 groups, 42 groups were tested, 1 group was blank control group, each group had 5 mice, the drug feeding test was carried out three times a day with a dose of 2ml/kg,10ml/kg, and 20ml/kg (human recommended dose 100ml/50 kg-2 ml/kg) respectively 1, 5, and 10 times the human recommended dose, the drug feeding was carried out, the drug feeding was stopped half a year and the observation test was carried out half a year later, no toxicity symptoms were observed after the drug feeding, and the normal activity of the mice half a year later was observed.
Case 1, plum, 40 years old at one year, chronic antral gastritis for 5 years, was administered according to the prescription of example 2 three times a day, 14 days without drug withdrawal, with disappearance of gastritis symptoms and no recurrence symptoms after 2 years.
Case 2, age 26 of Wangzhennian, positive test for C14 of H.pylori, was administered according to the prescription of example 2 three times a day, 14 days off, and negative test for C14 after one month.
Case 3, wu, 65 years old, gastric ulcer 10 years old, was taken three times a day, 14 days discontinued, gastric ulcer symptoms disappeared, and no recurrence symptoms occurred after 5 years, according to the prescription of example 11.
Case 4, the constipation of the polygonum of 36 years old in certain age, caused by ulcerative colitis, was taken three times a day according to the prescription of example 3, the constipation was significantly improved on day 3 after the administration, the constipation symptom disappeared on day 7, the stool was normal, the administration was stopped on day 14, and no constipation symptom was observed for half a year.
According to the statistics of the inventor data, the cure rate of the invention reaches more than 90 percent, and the symptoms of the patient can be quickly relieved and cured.
The above description is only a preferred embodiment of the present invention, and therefore should not be taken as limiting the scope of the invention, which is defined by the appended claims.
Claims (7)
1. Application of herba Aristolochiae Kamtschatici and its extract in preparing medicine for treating gastrointestinal diseases is provided.
2. The use as claimed in claim 1, wherein the extract comprises an alcohol or water extracted liquid or solid of the burclover and mixtures thereof.
3. A pharmaceutical formulation for treating gastrointestinal diseases is characterized in that the pharmaceutical formulation contains the leaf of Equisetum rotundus or the extract thereof.
4. The pharmaceutical formulation for the treatment of gastrointestinal disorders according to claim 3, wherein the pharmaceutical formulation further comprises a handless cup.
5. The pharmaceutical formulation for the treatment of gastrointestinal diseases according to claim 3, wherein the mass fraction of the Sarcandra glabra or the extract thereof in the pharmaceutical formulation is m, and 0% < m < 100%.
6. The pharmaceutical formulation for treating gastrointestinal diseases according to claim 4, wherein the weight ratio of the burclover or the extract thereof to the herba cistanches is 1: 0.01-0.5.
7. The pharmaceutical formulation for the treatment of gastrointestinal disorders according to any one of claims 3 to 6, wherein the pharmaceutical formulation is formulated as a tablet, pill, capsule, suspension, powder, aqueous, bulk drug pellet or emulsion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110172782.7A CN112691130B (en) | 2021-02-08 | 2021-02-08 | Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110172782.7A CN112691130B (en) | 2021-02-08 | 2021-02-08 | Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112691130A true CN112691130A (en) | 2021-04-23 |
| CN112691130B CN112691130B (en) | 2022-06-17 |
Family
ID=75516729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110172782.7A Active CN112691130B (en) | 2021-02-08 | 2021-02-08 | Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112691130B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006436A (en) * | 2022-06-30 | 2022-09-06 | 广西壮至力健康科技有限公司 | Application of herba Otteliae Convolvuli and its extract in preparing medicine for treating alcoholic liver disease |
| CN115590100A (en) * | 2022-11-12 | 2023-01-13 | 广西自由贸易试验区南宁片区庆壕生物科技有限公司（Cn） | Health-care tea, preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550691A (en) * | 2013-10-29 | 2014-02-05 | 李怀元 | Preparation method of pharmaceutical compositions for treating epigastric pain |
-
2021
- 2021-02-08 CN CN202110172782.7A patent/CN112691130B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550691A (en) * | 2013-10-29 | 2014-02-05 | 李怀元 | Preparation method of pharmaceutical compositions for treating epigastric pain |
Non-Patent Citations (2)
| Title |
|---|
| 云南省药物研究所: "《云南民族药志.第1卷》", 31 March 2008, 云南民族出版社 * |
| 余甘霖等: "《长江三峡中草药图谱》", 31 December 2009, 中国中医药出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006436A (en) * | 2022-06-30 | 2022-09-06 | 广西壮至力健康科技有限公司 | Application of herba Otteliae Convolvuli and its extract in preparing medicine for treating alcoholic liver disease |
| CN115590100A (en) * | 2022-11-12 | 2023-01-13 | 广西自由贸易试验区南宁片区庆壕生物科技有限公司（Cn） | Health-care tea, preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112691130B (en) | 2022-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112691130B (en) | Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation | |
| CN101569739B (en) | Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN104383288A (en) | Pharmaceutical composition for treating bovine pneumonia and preparation method of pharmaceutical composition for treating bovine pneumonia | |
| CN103191167B (en) | Application of eupatorium Chinese | |
| CN105381153A (en) | Traditional Chinese medicine preparation for treating bronchitis and preparation method thereof | |
| CN104997860A (en) | Traditional Chinese medicine preparation for treating duodenal ulcer and preparation method thereof | |
| CN105194364A (en) | Medicinal composition for local burn nursing | |
| CN113769030A (en) | Chinese herbal medicine capable of preventing gout and preparation method thereof | |
| CN102389465B (en) | Traditional Chinese medicine composition for treating gastropathy and its preparation method | |
| CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
| CN102258583B (en) | Traditional Chinese medicine preparation for treating chronic and nonspecific ulcerative colitis and preparation method thereof | |
| CN105998686A (en) | Stomach medicine preparation, preparation method and application thereof | |
| CN110898137A (en) | Pills for treating hyperthyroidism and preparation method and application thereof | |
| CN105147802A (en) | Composition for treating swine mycoplasmal pneumonia and porcine contagious pleuropneumonia and preparation method | |
| CN103933154A (en) | Traditional Chinese medicine composition for treating gout disease and preparation method thereof | |
| CN114129692B (en) | Traditional Chinese medicine composition for treating furunculosis and preparation method and application thereof | |
| CN103479822B (en) | Traditional Chinese unguent capable of preventing and treating wound infection and preparation method of traditional Chinese unguent | |
| CN103705692B (en) | A kind of Chinese medicine preparation for the treatment of acute gastroenteritis | |
| CN109718283B (en) | Traditional Chinese medicine composition for relieving asthma and reducing phlegm and preparation method thereof | |
| CN104758842A (en) | Traditional Chinese medicinal preparation for treating acute appendicitis | |
| CN105395879A (en) | Traditional Chinese medicine used for treating senile chronic bronchitis | |
| CN105012775A (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN117100829A (en) | Traditional Chinese medicine preparation for treating novel coronavirus infection and preparation method thereof | |
| CN117338879A (en) | Traditional Chinese medicine preparation for ulcerative colitis and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |